⌕
Invesco Biotechnology & Genome ETF · PBE · NYSE Arca
A sector position · not Tenet-scored
Compare
$95.95+0.27%At close
$95.95+0.26 (+0.27%)
At close: Nov 18, 2026, 4:00 PM ET· NYSE Arca · USD

Invesco Biotechnology & Genome ETF (PBE) Expense Ratio

Sources Fund holdings disclosures Fund disclosuresHow we compute thisNot investment advice

A 0.59% expense ratio sounds abstract. Here's what it is versus its Healthcare peers, and what any fee actually costs you in real dollars over time.

Expense ratio vs category

0.59%$59 per $10,000/yr
PBE0.59%
Category avg0.76%

Below category average. This fund costs about 0.77× the typical Healthcare peer's fee. Cheap for its category, though a plain broad-index fund can still cost less.

Peer set: US-listed Healthcare equity ETFs · fee point-in-time.

Fee-drag calculator · in dollars

Amount invested
Holding period
PBE fee cost (0.59%)$10,128
If it charged category avg (0.76%)$12,921
You keep$2,793

Fee dollars over 20 years on $25,000, assuming 7%/yr growth. Dollarising the fee is what actually changes behaviour.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.